Skip to main navigation

Main navigation

  • About
    • Who We Are
    • Management
    • Board of Directors
    • Scientific Advisory Board
  • Pipeline
  • Technology
  • Therapeutic Areas
    • Acne Vulgaris
    • Subtype II Papulopustular Rosacea
    • Palmoplantar Keratoderma
  • Investors
    • Investor Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Analyst Coverage
    • Financial Information
    • Stock Information
    • Shareholder Services
  • Media
  • Contact

Events & Presentations

Featured Presentation
Patidegib Acquisition Call

Upcoming Events

There are currently no events to display.

Past Events

Date Title
Jan 27, 2023 at
8:30 AM EST
Patidegib Acquisition Call
Click here for webcast
Jun 08, 2022 at
8:30 AM EDT
2022 Jefferies Global Healthcare Conference
Click here for webcast
May 24, 2022 at
7:00 AM EDT
H.C. Wainwright Global Investment Conference
Click here for webcast

Presentations

Date Title
January 27, 2023
Patidegib Acquisition Call
November 10, 2022
Sol-Gel Corporate Presentation
April 18, 2022
Papulopustular Rosacea: Where are we Now & What is New
January 21, 2020
Twyneo® (Microencapsulated Benzoyl Peroxide 3%, Tretinoin 0.1%) Phase 3 Efficacy and Safety: Results from Two Randomized Controlled Clinical Trials
January 21, 2020
Characterization of Microencapsulated Benzoyl Peroxide (E-BPO) for the Treatment of Papulopustular Rosacea
January 21, 2020
Efficacy and Safety of Microencapsulated Benzoyl Peroxide (E-BPO) Cream, 5% in Papulopustular Rosacea: Results from Two Phase 3, Vehicle-Controlled Trials
January 8, 2020
Sol-Gel Announces Positive Top-Line Phase 3 Trial Results of Twyneo® for the Treatment of Acne
July 25, 2019
Sol-Gel Technologies Analyst and Investor Day Presentation
July 8, 2019
Sol-Gel Announces Positive Top-Line Results from Epsolay® Phase 3 Program in Papulopustular Rosacea
February 14, 2018
TWIN Drug Product Candidate Presentation
February 14, 2018
VERED Drug Product Candidate Presentation

Investor Relations

  • Investor Overview
  • Press Releases
  • Events & Presentations
    • Events
  • Corporate Governance
    • Documents and Charters
    • Committee Composition
  • Analyst Coverage
  • Financial Information
    • SEC Filings
    • Proxy Statement
  • Stock Information
    • Stock Quote & Chart
  • Shareholder Services
    • FAQs
    • Contact
    • Email Alerts

Shareholder Tools

Print
Print
Email Alerts
Email Alerts
RSS Feeds
RSS Feeds

Who We Are

We are a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases.

What We Do

Footer What We Do

  • About
  • Technology
  • Pipeline

Get In Touch

Footer Get In Touch

  • Contact Us
  • Partnering

Subscribe!

Subscribe to receive updates
Sign-up

© 2023 Sol-Gel Technologies Ltd. All Rights Reserved